stars 1 stars 2 stars 3

CORD iPS is a biotechnology company that combines modern medicine, science, and technology in order to make innovative products and services available in Serbia and customized for each client. We made it possible for clients to invest in the future health of their child in the right and safest way. Driven by the experience of the largest biomedical centers for the cryopreservation of stem cells Vita 34 and Seracell from Germany, unlocking the power of the whole genome by cooperating with Illumina from USA, and collaborating with Novogenia from Austria, we enable high-tech medical services and products to be widely available in Serbia. Exclusive agent for: CORD BLOOD INDUSTRY Seracell Stammzelltechnologie GmbH, Germany Vita34 AG, Germany GENETIC TESTING Illumina inc., USA Novogenia, Austria DNA Plus, Germany *CORD iPS is the triple-A rated company (AAA - Bisnode)

CORD iPS Questions

Vladimir Jesic is the CEO of CORD iPS.

15 people are employed at CORD iPS.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users